This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Azienda Ospedaliera Universitaria Senese, Universitá Degli Studi Di Siena. Active years: 2021-2023.
Company Filing History:
2 out of 3 
1 out of 18 Years Active: 2021-2023
Title: Annalaura Brai: Innovator in Antiviral Compounds
Introduction
Annalaura Brai is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral compounds. With a total of 3 patents to her name, her work focuses on innovative solutions for combating viral infections.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Antiviral compounds and use thereof." This invention relates to compounds of formula (I) that serve as broad-spectrum antiviral agents. These compounds are particularly useful in treating diseases caused by enveloped viruses. Another notable patent is "Use of DDX3 inhibitors as antiproliferative agents," which refers to compounds endowed with DDX3 inhibitory activity. This invention includes relative pharmaceutical compositions and their application as antihyperproliferative agents.
Career Highlights
Throughout her career, Annalaura has worked with esteemed institutions such as Azienda Ospedaliera Universitaria Senese and Università Degli Studi Di Siena. Her research has significantly advanced the understanding and treatment of viral diseases.
Collaborations
Annalaura has collaborated with notable colleagues, including Maurizio Botta and Cristina Tintori. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Annalaura Brai's contributions to antiviral research exemplify her dedication to improving public health through innovative solutions. Her patents reflect her commitment to advancing medical science and providing effective treatments for viral infections.